In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $19.32, down -7.34% from its previous closing price of $20.85. In other words, the price has decreased by -$7.34 from its previous closing price. On the day, 32.23 million shares were traded. HIMS stock price reached its highest trading level at $21.38 during the session, while it also had its lowest trading level at $19.1501.
Ratios:
To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.14. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On August 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Manuel Anja bought 4,000 shares for $26.94 per share. The transaction valued at 107,760 led to the insider holds 4,000 shares of the business.
Manuel Anja bought 1,000 shares of HIMS for $24,500 on Nov 14 ’24. The Director now owns 5,000 shares after completing the transaction at $24.50 per share. On Nov 13 ’24, another insider, Okupe Oluyemi, who serves as the Chief Financial Officer of the company, sold 142,886 shares for $29.93 each. As a result, the insider received 4,276,609 and left with 112,186 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 4221014272 and an Enterprise Value of 3978303488. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.69, and their Forward P/E ratio for the next fiscal year is 21.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.15 while its Price-to-Book (P/B) ratio in mrq is 9.56. Its current Enterprise Value per Revenue stands at 3.203 whereas that against EBITDA is 66.614.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $30.44, while it has fallen to a 52-week low of $7.40. The 50-Day Moving Average of the stock is -2.21%, while the 200-Day Moving Average is calculated to be 13.16%.
Shares Statistics:
It appears that HIMS traded 12.17M shares on average per day over the past three months and 29941560 shares per day over the past ten days. A total of 205.10M shares are outstanding, with a floating share count of 177.18M. Insiders hold about 18.91% of the company’s shares, while institutions hold 56.08% stake in the company. Shares short for HIMS as of 1730332800 were 33843786 with a Short Ratio of 2.78, compared to 1727654400 on 24764222. Therefore, it implies a Short% of Shares Outstanding of 33843786 and a Short% of Float of 17.709999.
